TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its third quarter 2017 financial and operating results on Tuesday, November 7, 2017 before market opens. The company will host a conference call on Tuesday, November 7, 2017 at 8:30 a.m. Eastern Time.
To access the call live, please dial 416-340-2216 or 1-866-225-2055. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, November 14, 2017 by dialing 905-694-9451 or 1-800-408-3053, using access code: 7324148#.
Acerus Pharmaceuticals Corporation is a fully-integrated, Canadian specialty pharmaceutical company engaged in the development, manufacture, marketing and distribution of innovative, branded products in Men’s and Women’s Health. Acerus’ shares trade on TSX under the symbol ASP. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171031005215/en/
Acerus Pharmaceuticals Corporation
Tricia Symmes, 416-509-2116
Chief Operating Officer
Source: Acerus Pharmaceuticals Corporation